vs

Side-by-side financial comparison of Kiniksa Pharmaceuticals International, plc (KNSA) and Stitch Fix, Inc. (SFIX). Click either name above to swap in a different company.

Stitch Fix, Inc. is the larger business by last-quarter revenue ($342.1M vs $202.1M, roughly 1.7× Kiniksa Pharmaceuticals International, plc). Kiniksa Pharmaceuticals International, plc runs the higher net margin — 7.0% vs -1.9%, a 8.9% gap on every dollar of revenue. On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs 7.3%). Kiniksa Pharmaceuticals International, plc produced more free cash flow last quarter ($53.3M vs $5.6M). Over the past eight quarters, Kiniksa Pharmaceuticals International, plc's revenue compounded faster (59.1% CAGR vs 1.8%).

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

Stitch Fix, Inc. is an online personal styling service in the United States. It uses recommendation algorithms and data science to personalize clothing items based on size, budget and style. The company was founded in 2011 and had an initial public offering in 2017 with a valuation of $1.6 billion. Stitch Fix generated $1.6 billion in net revenue in its fiscal year 2023, a decrease of 21% year-over-year and reported 3,297,000 active clients in September 2023. It is headquartered in San Franci...

KNSA vs SFIX — Head-to-Head

Bigger by revenue
SFIX
SFIX
1.7× larger
SFIX
$342.1M
$202.1M
KNSA
Growing faster (revenue YoY)
KNSA
KNSA
+57.6% gap
KNSA
65.0%
7.3%
SFIX
Higher net margin
KNSA
KNSA
8.9% more per $
KNSA
7.0%
-1.9%
SFIX
More free cash flow
KNSA
KNSA
$47.7M more FCF
KNSA
$53.3M
$5.6M
SFIX
Faster 2-yr revenue CAGR
KNSA
KNSA
Annualised
KNSA
59.1%
1.8%
SFIX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KNSA
KNSA
SFIX
SFIX
Revenue
$202.1M
$342.1M
Net Profit
$14.2M
$-6.4M
Gross Margin
89.6%
43.6%
Operating Margin
9.8%
-2.5%
Net Margin
7.0%
-1.9%
Revenue YoY
65.0%
7.3%
Net Profit YoY
259.8%
-1.7%
EPS (diluted)
$0.18
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KNSA
KNSA
SFIX
SFIX
Q4 25
$202.1M
$342.1M
Q3 25
$180.9M
$311.2M
Q2 25
$156.8M
$325.0M
Q1 25
$137.8M
$312.1M
Q4 24
$122.5M
$318.8M
Q3 24
$112.2M
$319.6M
Q2 24
$108.6M
$322.7M
Q1 24
$79.9M
$330.4M
Net Profit
KNSA
KNSA
SFIX
SFIX
Q4 25
$14.2M
$-6.4M
Q3 25
$18.4M
$-8.6M
Q2 25
$17.8M
$-7.4M
Q1 25
$8.5M
$-6.5M
Q4 24
$-8.9M
$-6.3M
Q3 24
$-12.7M
$-36.5M
Q2 24
$-3.9M
$-21.3M
Q1 24
$-17.7M
$-35.5M
Gross Margin
KNSA
KNSA
SFIX
SFIX
Q4 25
89.6%
43.6%
Q3 25
88.8%
43.6%
Q2 25
88.1%
44.2%
Q1 25
87.0%
44.5%
Q4 24
85.4%
45.4%
Q3 24
82.1%
44.6%
Q2 24
88.7%
45.5%
Q1 24
86.7%
43.4%
Operating Margin
KNSA
KNSA
SFIX
SFIX
Q4 25
9.8%
-2.5%
Q3 25
13.3%
-3.6%
Q2 25
12.9%
-3.0%
Q1 25
9.6%
-2.9%
Q4 24
-15.7%
-2.8%
Q3 24
-8.6%
-13.1%
Q2 24
-0.1%
-7.7%
Q1 24
-20.7%
-11.5%
Net Margin
KNSA
KNSA
SFIX
SFIX
Q4 25
7.0%
-1.9%
Q3 25
10.2%
-2.8%
Q2 25
11.4%
-2.3%
Q1 25
6.2%
-2.1%
Q4 24
-7.3%
-2.0%
Q3 24
-11.3%
-11.4%
Q2 24
-3.6%
-6.6%
Q1 24
-22.2%
-10.8%
EPS (diluted)
KNSA
KNSA
SFIX
SFIX
Q4 25
$0.18
$-0.05
Q3 25
$0.23
$-0.06
Q2 25
$0.23
$-0.06
Q1 25
$0.11
$-0.05
Q4 24
$-0.11
$-0.05
Q3 24
$-0.18
$-0.29
Q2 24
$-0.06
$-0.18
Q1 24
$-0.25
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KNSA
KNSA
SFIX
SFIX
Cash + ST InvestmentsLiquidity on hand
$414.1M
$244.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$567.6M
$204.1M
Total Assets
$763.6M
$530.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KNSA
KNSA
SFIX
SFIX
Q4 25
$414.1M
$244.2M
Q3 25
$352.1M
$234.9M
Q2 25
$307.8M
$234.2M
Q1 25
$268.3M
$219.1M
Q4 24
$243.6M
$253.3M
Q3 24
$223.8M
$247.0M
Q2 24
$218.8M
$244.5M
Q1 24
$213.6M
$229.8M
Stockholders' Equity
KNSA
KNSA
SFIX
SFIX
Q4 25
$567.6M
$204.1M
Q3 25
$535.4M
$203.0M
Q2 25
$495.0M
$200.4M
Q1 25
$457.5M
$197.8M
Q4 24
$438.4M
$190.5M
Q3 24
$437.0M
$187.0M
Q2 24
$435.1M
$208.9M
Q1 24
$431.9M
$213.3M
Total Assets
KNSA
KNSA
SFIX
SFIX
Q4 25
$763.6M
$530.7M
Q3 25
$712.3M
$480.6M
Q2 25
$661.1M
$484.7M
Q1 25
$599.3M
$472.6M
Q4 24
$580.6M
$507.1M
Q3 24
$555.3M
$486.9M
Q2 24
$542.4M
$537.0M
Q1 24
$519.7M
$538.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KNSA
KNSA
SFIX
SFIX
Operating Cash FlowLast quarter
$53.9M
$10.9M
Free Cash FlowOCF − Capex
$53.3M
$5.6M
FCF MarginFCF / Revenue
26.4%
1.6%
Capex IntensityCapex / Revenue
0.3%
1.6%
Cash ConversionOCF / Net Profit
3.80×
TTM Free Cash FlowTrailing 4 quarters
$136.4M
$4.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KNSA
KNSA
SFIX
SFIX
Q4 25
$53.9M
$10.9M
Q3 25
$33.7M
$7.0M
Q2 25
$28.1M
$20.5M
Q1 25
$22.3M
$-16.2M
Q4 24
$18.8M
$14.3M
Q3 24
$-2.2M
$8.2M
Q2 24
$5.2M
$21.7M
Q1 24
$4.0M
$-22.3M
Free Cash Flow
KNSA
KNSA
SFIX
SFIX
Q4 25
$53.3M
$5.6M
Q3 25
$33.0M
$2.8M
Q2 25
$27.9M
$16.0M
Q1 25
$22.2M
$-19.4M
Q4 24
$18.6M
$9.9M
Q3 24
$4.5M
Q2 24
$18.9M
Q1 24
$3.9M
$-26.1M
FCF Margin
KNSA
KNSA
SFIX
SFIX
Q4 25
26.4%
1.6%
Q3 25
18.2%
0.9%
Q2 25
17.8%
4.9%
Q1 25
16.1%
-6.2%
Q4 24
15.2%
3.1%
Q3 24
1.4%
Q2 24
5.9%
Q1 24
4.9%
-7.9%
Capex Intensity
KNSA
KNSA
SFIX
SFIX
Q4 25
0.3%
1.6%
Q3 25
0.4%
1.4%
Q2 25
0.1%
1.4%
Q1 25
0.1%
1.0%
Q4 24
0.2%
1.4%
Q3 24
0.0%
1.2%
Q2 24
0.0%
0.9%
Q1 24
0.1%
1.1%
Cash Conversion
KNSA
KNSA
SFIX
SFIX
Q4 25
3.80×
Q3 25
1.83×
Q2 25
1.58×
Q1 25
2.61×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons